US pharma major Eli Lilly, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive top-line ...

The New Drug Application (NDA) for the combination of Elunate (fruquintinib) and TYVYT (sintilimab injection) has been ...

Genesis Molecular AI and Incyte announced a new kind of deal, with Incyte’s proprietary experimental data powering ...

Privately-held UK based AMR Bio has announced its launch as a clinical phase biotechnology company focused on one of the most ...

American States are rolling out complex drug price-setting efforts - but there is no evidence yet that patients are or will ...

Scenic Biotech has progressed enormously since it was founded in 2017 as a spin-out from the Netherlands Cancer Institute and ...

A clinical-stage Israeli biotech advancing steroid-free therapies for ocular diseases, with a lead program in Phase III ...

Schizophrenia is a persistent and disabling mental illness that can impact all aspects of an individual’s life, including ...

California-based obesity-focused clinical-stage pharma Aardvark Therapeutics saw its shares tumble nearly 26% to $4.99, after it announced that the US Food and Drug Administration (FDA) has placed a ...

Bayer has announced that the US Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for Kerendia (finerenone), which is ...

The UK subsidiary of Japan’s Otsuka (TYO: 4578) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Dawnzera (donidalorsen) for the routine prevention ...

US rare disease drugmaker BioMarin (Nasdaq: BMRN) said its growth disorder therapy Voxzogo (vosoritide) met the primary endpoint in a pivotal Phase III study in children with hypochondroplasia, ...